Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Clinical trial NCT03109288 · RECRUITING
Trial details
- NCT number
- NCT03109288
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-11
- Primary completion
- 2027-01-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.